Critically Evaluating Gene Testing in Personalised Medicine with Tommy Wood

Published: Nov. 21, 2019, 1 a.m.

b'

Professor Tommy Wood explains the effects of specific single nucleotide polymorphisms (SNPs) on an individual\\u2019s health outcomes. From his analysis of what has been presented in the literature and widely accepted in functional medicine circles, Tommy discusses the relevance of SNP testing and highlights the difference between \\u201crelative risk\\u201d and \\u201cpersonal risk\\u201d whilst expanding on additional factors that should take precedence when treating a patient.

\\n\\n

\\u2022 Professor Tommy Wood discusses his journey into genetic testing and SNPs (06:00)
\\n\\u2022 Single nucleotide polymorphisms (SNPs), gene testing and phenotypes (11:21)
\\n\\u2022 Fat mass and obesity-associated SNP and obesity risk (14:15)
\\n\\u2022 FOX03 SNP and lifestyle interventions (18:44)
\\n\\u2022 SNPs associated with risk of obesity (20:00)
\\n\\u2022 Melatonin receptor 1B SNP effect on elevated fasting blood sugar (23:17)
\\n\\u2022 Pre-diabetic risk, SNPs and environmental factors (25:11)
\\n\\u2022 Catechol-O-methyltransferase SNPs, dopamine and cognitive function (32:39)
\\n\\u2022 Methylenetetrahydrofolate reductase SNPs, homocysteine and folate (38:13)
\\n\\u2022 The personalized diet and SNPs (45:27)
\\n\\u2022 The placebo/nocebo effect of genes (50:15)
\\n\\u2022 Utilising testing outside of genetic testing in clinical practice (56:58)

'